Sun Pharma announces manufacturing consolidation

Sun Pharma announces manufacturing consolidation

Mumbai, May 02, 2014: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) today announced that, as a part of its manufacturing consolidation in the US, it has notified the Workforce Development Agency for the State of Michigan regarding its decision to cease manufacturing operations and close the Detroit (Caraco Pharmaceutical Laboratories, Ltd.) facility located at Elijah McCoy Detroit, Ml, USA. The Company has provided the requisite advance written notice of the facility closure to the employee union and all affected employees. 

- read the release (PDF)

Suggested Articles

Agios has withdrawn a European application for Tibsovo in AML after the same phase 1 data that earned it an FDA nod failed to impress the EMA.

Sanofi is reportedly considering a sale of some of its anti-inflammation drugs that could snare $234 million as the company pivots toward Dupixent.

Pfizer CEO Albert Bourla clarified that collecting safety data means a submission or FDA authorization won't happen until late November.